Lei Xia

2.2k total citations · 1 hit paper
66 papers, 1.5k citations indexed

About

Lei Xia is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lei Xia has authored 66 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Lei Xia's work include Cancer-related molecular mechanisms research (7 papers), Topic Modeling (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Lei Xia is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Topic Modeling (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Lei Xia collaborates with scholars based in China, United States and Canada. Lei Xia's co-authors include Yong Huang, Haige Chen, Feng Qiu, Liang Ying, Yonghui Chen, Yawei Wang, Yidong Liu, Jianjun Zhang, Ning Xu and Yi Luo and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lei Xia

62 papers receiving 1.5k citations

Hit Papers

Hepatocellular carcinoma: signaling pathways and therapeu... 2025 2026 2025 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Xia China 19 683 548 280 206 159 66 1.5k
Ying Su China 22 700 1.0× 240 0.4× 213 0.8× 106 0.5× 138 0.9× 52 1.4k
Dongxiao Shen United States 16 847 1.2× 166 0.3× 219 0.8× 166 0.8× 78 0.5× 24 1.6k
Wen‐Lung Ma Taiwan 23 839 1.2× 480 0.9× 277 1.0× 458 2.2× 326 2.1× 68 1.9k
Hongzhi Sun China 26 935 1.4× 274 0.5× 291 1.0× 118 0.6× 258 1.6× 71 1.7k
Wook Jin South Korea 25 721 1.1× 358 0.7× 225 0.8× 334 1.6× 504 3.2× 55 1.8k
Shuai Huang China 24 1.2k 1.8× 764 1.4× 178 0.6× 130 0.6× 340 2.1× 69 2.1k
Lingyan Xu China 25 1.0k 1.5× 350 0.6× 457 1.6× 108 0.5× 304 1.9× 105 2.2k
Ying Lu China 26 992 1.5× 564 1.0× 213 0.8× 199 1.0× 251 1.6× 81 1.9k
Daniel R. Schmidt United States 12 766 1.1× 313 0.6× 261 0.9× 110 0.5× 629 4.0× 22 1.6k
Ayoung Kim South Korea 16 968 1.4× 511 0.9× 305 1.1× 79 0.4× 221 1.4× 33 1.7k

Countries citing papers authored by Lei Xia

Since Specialization
Citations

This map shows the geographic impact of Lei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Xia more than expected).

Fields of papers citing papers by Lei Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Xia. The network helps show where Lei Xia may publish in the future.

Co-authorship network of co-authors of Lei Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Xia. A scholar is included among the top collaborators of Lei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Xia. Lei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Wenting, Lilin Yi, Xiuyu Shi, et al.. (2025). APP lysine 612 lactylation ameliorates amyloid pathology and memory decline in Alzheimer’s disease. Journal of Clinical Investigation. 135(1). 11 indexed citations
2.
Yi, Lilin, Junjie Li, Yan He, et al.. (2025). ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer’s disease. Experimental & Molecular Medicine. 57(5). 1032–1046. 1 indexed citations
3.
Wang, Siying, Lei Xia, Kui Ming Chan, et al.. (2025). Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduction and Targeted Therapy. 10(1). 35–35. 62 indexed citations breakdown →
4.
Luo, Dan, et al.. (2024). lncRNA JPX Promotes Tumor Progression by Interacting with and Destabilizing YTHDF2 in Cutaneous Melanoma. Molecular Cancer Research. 22(6). 524–537. 9 indexed citations
5.
Xia, Lei, et al.. (2024). Alpinia officinarum Hance: a comprehensive review of traditional uses, phytochemistry, pharmacokinetic and pharmacology. Frontiers in Pharmacology. 15. 1414635–1414635. 9 indexed citations
7.
Shao, Fang, Jun Ding, Yongling Ning, et al.. (2023). Whole β-glucan particle attenuates AOM/DSS-induced colorectal tumorigenesis in mice via inhibition of intestinal inflammation. Frontiers in Pharmacology. 14. 1017475–1017475. 7 indexed citations
8.
Zhu, Zhichao, et al.. (2023). Yeast β-glucan modulates macrophages and improves antitumor NK-cell responses in cancer. Clinical & Experimental Immunology. 214(1). 50–60. 20 indexed citations
9.
Feng, Yanhai, Qiong Zhang, Yongqing He, et al.. (2023). Mitophagy associated self-degradation of phosphorylated MAP4 guarantees the migration and proliferation responses of keratinocytes to hypoxia. Cell Death Discovery. 9(1). 168–168. 1 indexed citations
10.
Bai, Yu, Lei Xia, Jie Pan, et al.. (2022). Oral administration of a whole glucan particle (WGP)-based therapeutic cancer vaccine targeting macrophages inhibits tumor growth. Cancer Immunology Immunotherapy. 71(8). 2007–2028. 14 indexed citations
11.
Ni, Shuangfei, et al.. (2021). EZH2 Mediates miR‐146a‐5p/HIF‐1α to Alleviate Inflammation and Glycolysis after Acute Spinal Cord Injury. Mediators of Inflammation. 2021(1). 5591582–5591582. 28 indexed citations
12.
Zhang, Zijie, Huan Tong, Zhifeng Xi, et al.. (2021). Neoadjuvant Programmed Cell Death 1 (PD-1) Inhibitor Treatment in Patients With Hepatocellular Carcinoma Before Liver Transplant: A Cohort Study and Literature Review. Frontiers in Immunology. 12. 653437–653437. 60 indexed citations
13.
Xia, Lei, Su Yang, Chengde Wang, et al.. (2020). Immunohistochemical Profiles of Matrix Metalloproteinases and Vascular Endothelial Growth Factor Overexpression in the Antoni B Area of Vestibular Schwannomas. World Neurosurgery. 144. e72–e79. 13 indexed citations
14.
Xia, Lei, Jie Shen, Qingfeng Meng, et al.. (2018). ANLN functions as a key candidate gene in cervical cancer as determined by integrated bioinformatic analysis. SHILAP Revista de lepidopterología. 7 indexed citations
15.
Xia, Lei, et al.. (2017). Mining Document Topics Based on Association Rules. Shuju fenxi yu zhishi faxian. 32(12). 50–56. 2 indexed citations
17.
Ying, Liang, Yong Huang, Haige Chen, et al.. (2012). Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Molecular BioSystems. 9(3). 407–411. 263 indexed citations
18.
Xu, Ning, Jianjun Zhang, Conghuan Shen, et al.. (2012). Cisplatin-induced downregulation of miR-199a-5p increases drug resistance by activating autophagy in HCC cell. Biochemical and Biophysical Research Communications. 423(4). 826–831. 164 indexed citations
19.
Zhang, Ziqi, Anna Lisa Gentile, Lei Xia, José Iria, & Sam Chapman. (2010). A random graph walk based approach to computing semantic relatedness using knowledge from Wikipedia. Language Resources and Evaluation. 3 indexed citations
20.
Xia, Lei. (2007). Two dimensional PCA using matrix volume measure in face recognition. Guangdian gongcheng. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026